CompletedPhase 1

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

NCT02077933

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Highlands Oncology Group

Fayetteville, Arkansas, United States

+21 additional locations

Save this trial

Highlands Oncology GroupFayetteville, Arkansas, United States
Memorial Sloan Kettering Cancer Center SC - BYL719Z2102New York, New York, United States
Novartis Investigative SiteBordeaux, France
Novartis Investigative SiteBordeaux, France
Novartis Investigative SiteParis, France
Novartis Investigative SiteVillejuif, France
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteEssen, Germany
Novartis Investigative SiteEssen, Germany
Novartis Investigative SiteHanover, Germany
Novartis Investigative SiteHong Kong, Hong Kong
Novartis Investigative SiteBudapest, Hungary
Novartis Investigative SiteAncona, AN, Italy
Novartis Investigative SiteMilan, MI, Italy
Novartis Investigative SiteModena, MO, Italy
Novartis Investigative SiteVerona, VR, Italy
Novartis Investigative SiteAmsterdam, Netherlands
Novartis Investigative SiteUtrecht, Netherlands
Novartis Investigative SiteBarcelona, Catalonia, Spain
Novartis Investigative SiteMadrid, Spain
Novartis Investigative SiteMadrid, Spain
Novartis Investigative SiteManchester, United Kingdom